Assessing efficacy of polyfunctional nanoparticles engineered for the delivery of multiple therapeutics in reduction of cardiac ischemia reperfusion injury

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

A reduction in heart muscle damage after a heart attack is associated with a reduction in heart failure and an increase in life expectancy. However to date many therapeutic agents are not successful at reducing muscle damage because of difficulty in delivering the drugs to the target site. This project will address these delivery issues by making use of multifunctional nanoparticles which will allow for targeted delivery and release of therapeutics directly to damaged tissue following injury.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2020

Funding Scheme: Early Career Fellowships

Funding Amount: $317,678.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cardiac hypertrophy | cardiac ischaemia | cardiovascular disease | infarction | ischaemia/reperfusion